JAB-24114

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameJAB-24114
Drug Alias NameJAB-24114
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamine-utilizing Enzyme inhibitors
TargetsGlutamine-utilizing Enzyme
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJacobio Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and Neck
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A